Comparative Proteomic and Transcriptomic Analysis of the Impact of Androgen Stimulation and Darolutamide Inhibition
Nevedomskaya, Ekaterina, Sugawara, Tatsuo, Baumgart, Simon J, Lesche, Ralf, Hahne, Hannes, Mumberg, Dominik, Haendler, Bernard
Published in Cancers (20.12.2022)
Published in Cancers (20.12.2022)
Get full text
Journal Article
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis
Sugawara, Tatsuo, Nevedomskaya, Ekaterina, Heller, Simon, Böhme, Annika, Lesche, Ralf, Ahsen, Oliver, Grünewald, Sylvia, Nguyen, Holly M., Corey, Eva, Baumgart, Simon J., Georgi, Victoria, Pütter, Vera, Fernández‐Montalván, Amaury, Vasta, James D., Robers, Matthew B., Politz, Oliver, Mumberg, Dominik, Haendler, Bernard
Published in Molecular oncology (01.03.2024)
Published in Molecular oncology (01.03.2024)
Get full text
Journal Article
BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients
Sugawara, Tatsuo, Lejeune, Pascale, Köhr, Silke, Neuhaus, Roland, Faus, Hortensia, Gelato, Kathy A, Busemann, Matthias, Cleve, Arwed, Lücking, Ulrich, von Nussbaum, Franz, Brands, Michael, Mumberg, Dominik, Jung, Klaus, Stephan, Carsten, Haendler, Bernard
Published in Oncotarget (02.02.2016)
Published in Oncotarget (02.02.2016)
Get full text
Journal Article
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
Sugawara, Tatsuo, Baumgart, Simon J., Nevedomskaya, Ekaterina, Reichert, Kristin, Steuber, Holger, Lejeune, Pascale, Mumberg, Dominik, Haendler, Bernard
Published in International journal of cancer (01.09.2019)
Published in International journal of cancer (01.09.2019)
Get full text
Journal Article
Abstract 1008: Comparative proteomics and transcriptomics analysis of the impact of androgen stimulation and darolutamide inhibition in a prostate cancer model
Nevedomskaya, Ekaterina, Baumgart, Simon J., Sugawara, Tatsuo, Lesche, Ralf, Mumberg, Dominik, Haendler, Bernard
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract 1795: Darolutamide demonstrates greater in vivo activity than enzalutamide in prostate cancer model with therapy-resistant androgen receptor mutation
Haendler, Bernard, Sugawara, Tatsuo, Baumgart, Simon J., Lejeune, Pascale
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract A028: In vitro and in vivo efficacy of the androgen receptor antagonist darolutamide in prostate cancer models
Sugawara, Tatsuo, Baumgart, Simon J., Reichert, Kristin, Lejeune, Pascale, Haendler, Bernard
Published in Cancer research (Chicago, Ill.) (15.08.2018)
Published in Cancer research (Chicago, Ill.) (15.08.2018)
Get full text
Journal Article
ASSEMBLED BATTERY AND POWER SOURCE DEVICE
SUZUKI Takashi, SENGOKU Eisuke, SUGAWARA Tatsuo, KAWASAKI Tatsuhiko, TSUNAKI Takuro
Year of Publication 01.09.2022
Get full text
Year of Publication 01.09.2022
Patent
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains
Bouché, Léa, Christ, Clara D, Siegel, Stephan, Fernández-Montalván, Amaury E, Holton, Simon J, Fedorov, Oleg, ter Laak, Antonius, Sugawara, Tatsuo, Stöckigt, Detlef, Tallant, Cynthia, Bennett, James, Monteiro, Octovia, Díaz-Sáez, Laura, Siejka, Paulina, Meier, Julia, Pütter, Vera, Weiske, Jörg, Müller, Susanne, Huber, Kilian V. M, Hartung, Ingo V, Haendler, Bernard
Published in Journal of medicinal chemistry (11.05.2017)
Published in Journal of medicinal chemistry (11.05.2017)
Get full text
Journal Article